Companies /Healthcare
Nektar Therapeutics
NASDAQ: NKTR Biotechnology
$38.27
▼ $0.95 (−2.42%) today
Markets closed · 4:40pm ET

Nektar Therapeutics (NKTR) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
80%
EPS beat rate
+20.82%
Avg. EPS surprise
Consecutive EPS beats
NKTR vs Market · 30-day return after each reportNKTRS&P 500
0%+40%+80%+108.9%+2.4%Q2 25+3.2%+2.5%Q3 25+13.6%+5.7%Q4 25−30.7%−1.7%Q1 26−7.7%−2.9%Q2 26
0%+40%+80%Q2 25Q3 25Q4 25Q1 26Q2 26
NKTR EPS Trend · estimate vs actualEstimateActual
$-4$-2$-3.12$-2.95Q2 25$-2.79$-1.87Q3 25$-3.50$-1.78Q4 25$-1.48$-1.82Q1 26$-2.04$-1.23Q2 26
$-4$-2Q2 25Q3 25Q4 25Q1 26Q2 26
NKTR Revenue Trend · estimate vs actualEstimateActual
$0$6.0M$12.0M$18.0M$9.4M$11.2MQ2 25$10.2M$11.8MQ3 25$10.4M$21.8MQ4 25$10.7M$10.9MQ1 26$10.5M$10.1MQ2 26
$0$6.0M$12.0M$18.0MQ2 25Q3 25Q4 25Q1 26Q2 26

How Often Does Nektar Therapeutics Beat Earnings Estimates?

Nektar Therapeutics beat EPS estimates in 4 of its last 5 reported quarters.

NKTR quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-1.23 est. $-2.04 +39.63% $10.1M est. $10.5M −3.24%
Q1 2026 $-1.82 est. $-1.48 −22.97% $10.9M est. $10.7M +1.59%
Q4 2025 $-1.78 est. $-3.50 +49.07% $21.8M est. $10.4M +109.52%
Q3 2025 $-1.87 est. $-2.79 +32.94% $11.8M est. $10.2M +15.62%
Q2 2025 $-2.95 est. $-3.12 +5.44% $11.2M est. $9.4M +18.68%

Figures from SEC filings and company reports. Not investment advice.